全文获取类型
| 收费全文 | 178360篇 |
| 免费 | 16757篇 |
| 国内免费 | 8151篇 |
专业分类
| 耳鼻咽喉 | 2397篇 |
| 儿科学 | 3863篇 |
| 妇产科学 | 2007篇 |
| 基础医学 | 32125篇 |
| 口腔科学 | 5694篇 |
| 临床医学 | 13224篇 |
| 内科学 | 23224篇 |
| 皮肤病学 | 4516篇 |
| 神经病学 | 9520篇 |
| 特种医学 | 3834篇 |
| 外国民族医学 | 121篇 |
| 外科学 | 14935篇 |
| 综合类 | 27268篇 |
| 现状与发展 | 51篇 |
| 预防医学 | 4628篇 |
| 眼科学 | 9279篇 |
| 药学 | 13557篇 |
| 29篇 | |
| 中国医学 | 5226篇 |
| 肿瘤学 | 27770篇 |
出版年
| 2024年 | 339篇 |
| 2023年 | 2498篇 |
| 2022年 | 4174篇 |
| 2021年 | 6493篇 |
| 2020年 | 5703篇 |
| 2019年 | 5537篇 |
| 2018年 | 5737篇 |
| 2017年 | 6091篇 |
| 2016年 | 6411篇 |
| 2015年 | 7192篇 |
| 2014年 | 10476篇 |
| 2013年 | 11632篇 |
| 2012年 | 10148篇 |
| 2011年 | 11288篇 |
| 2010年 | 9451篇 |
| 2009年 | 8972篇 |
| 2008年 | 9527篇 |
| 2007年 | 9731篇 |
| 2006年 | 8784篇 |
| 2005年 | 8091篇 |
| 2004年 | 7172篇 |
| 2003年 | 6206篇 |
| 2002年 | 5108篇 |
| 2001年 | 4409篇 |
| 2000年 | 3600篇 |
| 1999年 | 3243篇 |
| 1998年 | 3072篇 |
| 1997年 | 2797篇 |
| 1996年 | 2487篇 |
| 1995年 | 2188篇 |
| 1994年 | 1926篇 |
| 1993年 | 1621篇 |
| 1992年 | 1303篇 |
| 1991年 | 1233篇 |
| 1990年 | 950篇 |
| 1989年 | 898篇 |
| 1988年 | 841篇 |
| 1987年 | 672篇 |
| 1986年 | 616篇 |
| 1985年 | 859篇 |
| 1984年 | 765篇 |
| 1983年 | 552篇 |
| 1982年 | 601篇 |
| 1981年 | 477篇 |
| 1980年 | 419篇 |
| 1979年 | 303篇 |
| 1978年 | 241篇 |
| 1977年 | 146篇 |
| 1976年 | 109篇 |
| 1975年 | 42篇 |
排序方式： 共有10000条查询结果，搜索用时 31 毫秒
91.
《Cancer cell》2021,39(11):1497-1518.e11
- Download : Download high-res image (282KB)
- Download : Download full-size image
92.
随着对肿瘤热疗和肿瘤免疫微环境(TIME)的深入研究,近年来热疗对TIME的作用越来越受到学者们的重视。本文就目前国内外研究进展,对热疗与TIME中几类主要免疫细胞和免疫相关细胞因子的影响及作用机制作一综述。全面而透彻的了解热疗对TIME的调控作用,有助于为肿瘤治疗提供新的思路和方法。 相似文献
93.
94.
95.
《Vaccine》2016,34(24):2663-2670
Human metapneumovirus (HMPV) is a major cause of morbidity and mortality from acute lower respiratory tract illness, with most individuals seropositive by age five. Despite the presence of neutralizing antibodies, secondary infections are common and can be severe in young, elderly, and immunocompromised persons. Preclinical vaccine studies for HMPV have suggested a need for a balanced antibody and T cell immune response to enhance protection and avoid lung immunopathology. We infected transgenic mice expressing human HLA-A*0201 with HMPV and used ELISPOT to screen overlapping and predicted epitope peptides. We identified six novel HLA-A2 restricted CD8+ T cell (TCD8) epitopes, with M39–47 (M39) immunodominant. Tetramer staining detected M39-specific TCD8 in lungs and spleen of HMPV-immune mice. Immunization with adjuvant-formulated M39 peptide reduced lung virus titers upon challenge. Finally, we show that TCD8 from HLA-A*0201 positive humans recognize M39 by IFNγ ELISPOT and tetramer staining. These results will facilitate HMPV vaccine development and human studies. 相似文献
96.
《Molecular therapy》2020,28(6):1432-1441
- Download : Download high-res image (155KB)
- Download : Download full-size image
97.
98.
Bimal Bhindi Christine M. Lohse Phillip J. Schulte Ross J. Mason John C. Cheville Stephen A. Boorjian Bradley C. Leibovich R. Houston Thompson 《European urology》2019,75(5):766-772
Background
Partial nephrectomy (PN) is generally favored for cT1 tumors over radical nephrectomy (RN) when technically feasible. However, it can be unclear whether the additional risks of PN are worth the magnitude of renal function benefit.Objective
To develop preoperative tools to predict long-term estimated glomerular filtration rate (eGFR) beyond 30 d following PN and RN, separately.Design, setting, and participants
In this retrospective cohort study, patients who underwent RN or PN for a single nonmetastatic renal tumor between 1997 and 2014 at our institution were identified. Exclusion criteria were venous tumor thrombus and preoperative eGFR <15 ml/min/1.73 m2.Intervention
RN and PN.Outcome measurements and statistical analysis
Hierarchical generalized linear mixed-effect models with backward selection of candidate preoperative features were used to predict long-term eGFR following RN and PN, separately. Predictive ability was summarized using marginal , which ranges from 0 to 1, with higher values indicating increased predictive ability.Results and limitations
The analysis included 1152 patients (13 206 eGFR observations) who underwent RN and 1920 patients (18 652 eGFR observations) who underwent PN, with mean preoperative eGFRs of 66 ml/min/1.73 m2 (standard deviation [SD] = 18) and 72 ml/min/1.73 m2 (SD = 20), respectively. The model to predict eGFR after RN included age, diabetes, preoperative eGFR, preoperative proteinuria, tumor size, time from surgery, and an interaction between time from surgery and age (marginal ). The model to predict eGFR after PN included age, presence of a solitary kidney, diabetes, hypertension, preoperative eGFR, preoperative proteinuria, surgical approach, time from surgery, and interaction terms between time from surgery and age, diabetes, preoperative eGFR, and preoperative proteinuria (marginal ). Limitations include the lack of data on renal tumor complexity and the single-center design; generalizability needs to be confirmed in external cohorts.Conclusions
We developed preoperative tools to predict renal function outcomes following RN and PN. Pending validation, these tools should be helpful for patient counseling and clinical decision-making.Patient summary
We developed models to predict kidney function outcomes after partial and radical nephrectomy based on preoperative features. This should help clinicians during patient counseling and decision-making in the management of kidney tumors. 相似文献99.
100.
Lara Feulner Hamed S. Najafabadi Simon Tanguay Janusz Rak Yasser Riazalhosseini 《Urologic oncology》2019,37(2):166-175